| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.38 | 0.07 |